Design, synthesis and antidiabetic evaluation of oxazolone derivatives

Journal of Chemical Sciences

Volumn 123, Issue 3, 2011, Pages 335-341

  Mariappan, G ^a   Saha, B P ^a   Datta, Sriparna ^a   Kumar, Deepak ^a   Haldar, P K ^b  

^a Department of Medicinal Chemistry ^*  (India)

^b HIMALAYAN PHARMACY INSTITUTE   (India)

Author keywords

Acetyl glycine; Antiinflammatory; Hypoglycemic activity; Oxazolone scaffold

Indexed keywords

AMINO ACIDS;

ANTI DIABETICS; ANTI-INFLAMMATORIES; ANTIDIABETIC ACTIVITY; ANTIDIABETIC AGENTS; IN-VIVO; ROSIGLITAZONE; STREPTOZOTOCIN;

SCAFFOLDS;

EID: 79959355808     PISSN: 09743626     EISSN: 09737103     Source Type: Journal    
DOI: 10.1007/s12039-011-0079-2     Document Type: Article

References (36)

1. Ogbonnia S O, Odimegwu J I and Enwuru V N 2008 Afr. J. Biotechnol. 7 2535
2. Jr Porte D and Schwart M W 1996 Science 27 699
3. Kristova V, Liskoya S, Sotnikova S, Vojtko R and Kurtansky A 2008 Physiol. Res. 5 491
4. Sridhar G R 2000 Curr. Sci. 83 791
5. Ugochukwu N H, Babady N E, Cobourne M and Gasset S R 2003 J. Biosci. 28 1
6. Scoppola A, Montecchi F R, Mezinger G and Lala A 2001 Atherosclerosis 156 357
7. Owu D U, Antai A B, Udofia K H, Obembe A O, Obasi K O and Eteng M U 2006 J. Biosci. 31 575
8. Kesavulu M M, Giri R, Kameswara R B and Apparao C 2000 Diabetes Metabol. 26 387
9. Nayeemunnisa A 2009 Int. J. Diabetes Metabol. 17 105
10. Trivedi N A,Majumder B, Bhatt J D and Hemavathi K G 2004 Indian J. Pharmacol. 36 373
11. Kamaeswara R B, Giri R, Kesavulu M M and Apparao C 2001 J. Ethnopharmacol. 74 69
12. Lesieur and Aichaw H, Eur. Pat. 390 673/1990; 1991 Chem. Abstr. 114 143
13. Ando K and Asai N, Eur. Pat. 664 385/1990
14. Decas P and Jarry C, Eur. Pat. 929 392/1990
15. Doctorovich V B, Burgess E M, Lambropoulos J, Lednicer D, Derveer D V and Zalkow L H 1994 J. Med. Chem. 37 710
16. Pereira E R, Sanceleme M, Voldoire A and Prudhomme M 1997 Bioorg. Med. Chem. Lett. 7 2503
17. Viti G, Nannicini R, Ricci R, Pestellini V, Abelli L and Furio M 1994 Eur. J. Med. Chem. 29 401
18. Jason F S, Robert M A and Jetze T J 2007 Chem. Soc. Rev. 36 1432
19. Olefsky J M, Garvey W T, Henry R R, Brillon D, Matthael S and Freidenberg G R 1998 Am. J. Med. 5A 86
20. Defronzo R A and Ann 2000 Intern. Med. 133 73
21. Yoshioka T, Fujita T, Kanai T, Aizawa Y, Kuramada T, Hasegawa K and Horikoshi H 1989 J. Med. Chem. 32 421
22. Momose Y, Meguro K, Ikeda H, Hatanaka C, Oi S and Sohda T 1991 Chem. Pharm. Bull. 39 1440
23. Cantello B C C, Cawthorne M A, Haigh D, Hindley R M, Smith S A and Thurby P L 1994 Bioorg. Med. Chem. Lett. 4 1181
24. Krook A, Bjornholm M, Galuska D, Jiang X J, Fahlman R, Myers M G, Henriksson H W and Zierath J R 2000 Diabetes 49 284
25. Fuchtenbusch M, Stand E and Schatz H 2000 Exp. Clin. Endocrinol. Diabetes 108 151
26. Scheen A J 2001 Drug Saf. 24 873
27. Furniss B S, Hannaford A J, Smith P W G and Tatchell A R 1989 Vogel's textbook of practical organic chemistry (England: ELBS Longman) p. 907
28. Cantello B C C, Cawthorne M A, Haigh D, Hindley R M, Smith S A and Thurby P L 1994 Bioorg. Med. Chem. Lett. 4 1181
29. Litchfield J T andWilcoxon E J 1949 J. Pharmacol. Exp. Ther. 96 99
30. Raghavan P V 2000 Expert Consultant, CPCSEA, OECD, guideline no 420
31. Jarret R J, Keen H and Hardwick C 1970 Diabetes 19 724
32. Mackener C R, Saunders R N and Haettinger J R 1976 J. Toxi. Envi. Health 2 139
33. Mohamed A K, Bierhaus A, Sciekofer S, Tritschler H, Ziegler H and Nawroth P P 1999 Biofactors 10 175
34. Robert S and McDonald I M 2003 Burger's medicinal chemistry and drug discovery (New Jersey: John Wiley and Sons) pp. 28-30
35. Spiegelman B M 1998 Diabetes 47 507
36. Staels B and Auwerx J 1997 Curr. Pharm. Des. 3 1